China and Pfizer fail to reach Paxlovid public insurance deal

The antiviral has not been included in a national register that would have brought the cost down to consumers.


See also  MAS tipped to stand pat on Singdollar policy next week

This website uses cookies. By continuing to use this site, you accept our use of cookies.